In IIinkh et al., human monoclonals previously defined following natural infection with Bundibugyo virus ([23]; included in this study), all of which target the glycan cap and GP2 stalk region, were characterized with respect to their mechanisms of antiviral effects. The gene discussed is GP2; the disease is infection.